RhumbLine Advisers’s Kindred Healthcare KND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-86,046
| Closed | -$774K | – | 2962 |
|
|
2018
Q2 | $774K | Sell |
86,046
-128,733
| -60% | -$1.15M | ﹤0.01% | 2125 |
|
|
2018
Q1 | $1.97M | Buy |
214,779
+10,545
| +5% | +$97.6K | ﹤0.01% | 1616 |
|
|
2017
Q4 | $1.98M | Buy |
204,234
+22,122
| +12% | +$165K | ﹤0.01% | 1625 |
|
|
2017
Q3 | $1.24M | Buy |
182,112
+3,181
| +2% | +$27.1K | ﹤0.01% | 1872 |
|
|
2017
Q2 | $2.08M | Buy |
178,931
+449
| +0.3% | +$4.43K | ﹤0.01% | 1555 |
|
|
2017
Q1 | $1.49M | Buy |
178,482
+45,996
| +35% | +$360K | ﹤0.01% | 1719 |
|
|
2016
Q4 | $1.04M | Sell |
132,486
-2,956
| -2% | -$24.3K | ﹤0.01% | 1830 |
|
|
2016
Q3 | $1.38M | Buy |
135,442
+5,965
| +5% | +$66.2K | ﹤0.01% | 1641 |
|
|
2016
Q2 | $1.46M | Sell |
129,477
-23,515
| -15% | -$294K | ﹤0.01% | 1558 |
|
|
2016
Q1 | $1.89M | Buy |
152,992
+13,235
| +9% | +$137K | 0.01% | 1415 |
|
|
2015
Q4 | $1.67M | Buy |
139,757
+5,575
| +4% | +$72.2K | 0.01% | 1473 |
|
|
2015
Q3 | $2.11M | Buy |
134,182
+5,546
| +4% | +$112K | 0.01% | 1286 |
|
|
2015
Q2 | $2.61M | Buy |
128,636
+8,124
| +7% | +$186K | 0.01% | 1233 |
|
|
2015
Q1 | $2.87M | Buy |
120,512
+13,217
| +12% | +$268K | 0.01% | 1163 |
|
|
2014
Q4 | $1.95M | Buy |
107,295
+11,125
| +12% | +$220K | 0.01% | 1372 |
|
|
2014
Q3 | $1.87M | Buy |
96,170
+5,300
| +6% | +$115K | 0.01% | 1367 |
|
|
2014
Q2 | $2.1M | Buy |
90,870
+957
| +1% | +$23.4K | 0.01% | 1342 |
|
|
2014
Q1 | $2.11M | Sell |
89,913
-3,158
| -3% | -$65.3K | 0.01% | 1310 |
|
|
2013
Q4 | $1.84M | Sell |
93,071
-4,530
| -5% | -$73K | 0.01% | 1426 |
|
|
2013
Q3 | $1.31M | Sell |
97,601
-602
| -0.6% | -$8.66K | ﹤0.01% | 1600 |
|
|
2013
Q2 | $1.29M | Buy |
+98,203
| New | +$1.17M | ﹤0.01% | 1593 |
|
RhumbLine Advisers's KND Position: Q3 2018 in Review
RhumbLine Advisers sold out of Kindred Healthcare (KND) in Q3 2018, closing a stake of 86,046 shares — an estimated $774K sold.
RhumbLine Advisers first reported a position in KND in Q2 2013 and held it in 21 quarters. The position peaked at $2.87M in Q1 2015. 0 funds tracked by Wall St. Rank hold KND as of Q3 2018.
- RhumbLine Advisers reported no remaining Kindred Healthcare position as of Q3 2018 after selling out during the quarter.
- RhumbLine Advisers sold 86,046 Kindred Healthcare shares in Q3 2018, an estimated $774K.
- RhumbLine Advisers first reported a position in Kindred Healthcare in Q2 2013 and held it in 21 quarters.
- RhumbLine Advisers's Kindred Healthcare position peaked at $2.87M in Q1 2015.
- 0 funds tracked by Wall St. Rank held Kindred Healthcare as of Q3 2018.
Based on RhumbLine Advisers's 13F filing for Q3 2018, filed 7 Nov 2018.